The Vienna Prograf and Endothelial Progenitor Cell Extension Study
NCT03751332
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
87
Enrollment
OTHER
Sponsor class
Conditions
Immunosuppression
Renal Failure
Interventions
DRUG:
Tacrolimus
Sponsor
Medical University of Vienna